Sanofi
SAN
Real-time Euronext Paris - 09/20 05:35:02 pm
74.67EUR
-0.6%
Prev.75.1200
Open74.9700
High75.3300
Low74.2400
Volume2 747 102
Financials
Sales 2018 35 107 M
EBIT 2018 8 381 M
R. net 2018 5 005 M
Debt 2018 16 227 M
Rend. 2018 4,09%
P/E ratio 2018 18,23
P/E ratio 2019 16,95
EV / Sales 2018 3,14x
EV / Sales 2019 3,03x
Capitalization 94 023 M
Company
Sanofi engages in the research, production and distribution of pharmaceutical products.It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines.The Pharmaceuticals segment comprises the commercial operations of the following global franchises:...
Sector :
Pharmaceuticals - NEC
Calendar :
2018-11-02 Earnings Release
Trading Rating :
Investor Rating :
Latest news
09/20STUDIES FROM SANOFI UPDATE CURRENT DATA ON MUTATION RESEARCH [EXTENDING (Q)SARS TO INCORPORATE PROPRIETARY KNOWLEDGE FOR REGULATORY PURPOSES : is...
AQ
09/20SANOFI : Recent Research from Sanofi Pasteur Highlight Findings in Vaccines (Al-27 and P-31 NMR spectroscopy method development to quantify aluminum phosphate...
AQ
09/20SANOFI : Coughs Up $25 Million to Settle SEC FCPA Charges
AQ
09/20SANOFI : Coughs Up $25 Million to Settle SEC FCPA Charges
AQ
09/20SANOFI : Catholic Partner to Address Diabetes, Hypertension in Nigeria
AQ
09/19SANOFI : Galera raises $150 million, will hire staff for cancer-radiation side-effect drug
AQ
09/18SANOFI : unveils eczema drug data, as regulators mull label expansion
AQ
09/18REGENERON PHARMACEUTICALS : Sanofi pledges to keep up its restructuring efforts
RE
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishNeutral
Resistance75,775,783,8
Spread/Res.-1,3%-1,3%-11%
Spread/Supp.1,3%7,9%18%
Support73,769,263,4